Autophagy in hypertensive heart disease
- PMID: 20118246
- PMCID: PMC2838272
- DOI: 10.1074/jbc.R109.025023
Autophagy in hypertensive heart disease
Abstract
In response to hypertension, the heart manifests robust hypertrophic growth, which offsets load-induced elevations in wall stress. If sustained, this hypertrophic response is a major risk factor for systolic dysfunction and heart failure. Extensive research efforts have focused on the progression from hypertrophy to failure; however, precise understanding of underlying mechanisms remains elusive. Recently, autophagy, a process of cellular cannibalization, has been implicated. Autophagy is activated during ventricular hypertrophy, serving to maintain cellular homeostasis. Excessive autophagy eliminates, however, essential cellular elements and possibly provokes cell death, which together contribute to hypertension-related heart disease.
Figures


Similar articles
-
Autophagy in load-induced heart disease.Circ Res. 2008 Dec 5;103(12):1363-9. doi: 10.1161/CIRCRESAHA.108.186551. Circ Res. 2008. PMID: 19059838 Free PMC article. Review.
-
Autophagy in cardiac plasticity and disease.Pediatr Cardiol. 2011 Mar;32(3):282-9. doi: 10.1007/s00246-010-9883-6. Epub 2011 Jan 20. Pediatr Cardiol. 2011. PMID: 21249349 Free PMC article.
-
Autophagy and heart disease: implications for cardiac ischemia-reperfusion damage.Curr Mol Med. 2014;14(5):616-29. doi: 10.2174/1566524014666140603101520. Curr Mol Med. 2014. PMID: 24894175 Review.
-
Cardiomyocyte autophagy: remodeling, repairing, and reconstructing the heart.Curr Hypertens Rep. 2009 Dec;11(6):406-11. doi: 10.1007/s11906-009-0070-1. Curr Hypertens Rep. 2009. PMID: 19895751 Free PMC article. Review.
-
[The bidirectional roles of macroautophagy in the regulation of heart disease].Sheng Li Ke Xue Jin Zhan. 2011 Apr;42(2):81-5. Sheng Li Ke Xue Jin Zhan. 2011. PMID: 21770252 Review. Chinese.
Cited by
-
Vitamin D receptor deficiency increases systolic blood pressure by upregulating the renin-angiotensin system and autophagy.Exp Ther Med. 2022 Apr;23(4):314. doi: 10.3892/etm.2022.11243. Epub 2022 Mar 1. Exp Ther Med. 2022. PMID: 35369533 Free PMC article.
-
Research progress on programmed cell death of cardiomyocytes in pressure-overload hypertrophic cardiomyopathy.Apoptosis. 2025 Aug 14. doi: 10.1007/s10495-025-02146-5. Online ahead of print. Apoptosis. 2025. PMID: 40813538 Review.
-
miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy.Mol Cell Biochem. 2013 Jul;379(1-2):1-6. doi: 10.1007/s11010-012-1552-z. Epub 2013 May 10. Mol Cell Biochem. 2013. PMID: 23660952
-
Insulin-like growth factor-1 in myocardial ischemia-reperfusion injury: A review.Medicine (Baltimore). 2024 Mar 1;103(9):e37279. doi: 10.1097/MD.0000000000037279. Medicine (Baltimore). 2024. PMID: 38428899 Free PMC article. Review.
-
c-Src in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive rats.Pflugers Arch. 2011 Apr;461(4):437-46. doi: 10.1007/s00424-011-0932-7. Epub 2011 Feb 22. Pflugers Arch. 2011. PMID: 21340460
References
-
- Ezzati M., Lopez A. D., Rodgers A., Vander Hoorn S., Murray C. J. (2002) Lancet 360, 1347–1360 - PubMed
-
- Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J. (2005) Lancet 365, 217–223 - PubMed
-
- Wang Y., Wang Q. J. (2004) Arch. Intern. Med. 164, 2126–2134 - PubMed
-
- Vasan R. S., Larson M. G., Leip E. P., Evans J. C., O'Donnell C. J., Kannel W. B., Levy D. (2001) N. Engl. J. Med. 345, 1291–1297 - PubMed
-
- Lopez A. D., Mathers C. D., Ezzati M., Jamison D. T., Murray C. J. (2006) Lancet 367, 1747–1757 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical